Predicting Drug Resistance Using Deep Mutational Scanning

Drug resistance is a major healthcare challenge, resulting in a continuous need to develop new inhibitors. The development of these inhibitors requires an understanding of the mechanisms of resistance for a critical mass of occurrences. Recent genome editing technologies based on high-throughput DNA...

Full description

Bibliographic Details
Main Authors: Gur Pines, Reilly G. Fankhauser, Carrie A. Eckert
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/25/9/2265
_version_ 1827717040820977664
author Gur Pines
Reilly G. Fankhauser
Carrie A. Eckert
author_facet Gur Pines
Reilly G. Fankhauser
Carrie A. Eckert
author_sort Gur Pines
collection DOAJ
description Drug resistance is a major healthcare challenge, resulting in a continuous need to develop new inhibitors. The development of these inhibitors requires an understanding of the mechanisms of resistance for a critical mass of occurrences. Recent genome editing technologies based on high-throughput DNA synthesis and sequencing may help to predict mutations resulting in resistance by testing large mutagenesis libraries. Here we describe the rationale of this approach, with examples and relevance to drug development and resistance in malaria.
first_indexed 2024-03-10T19:54:10Z
format Article
id doaj.art-0ebe8c9a4b054fc598a8802d49c84548
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-10T19:54:10Z
publishDate 2020-05-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-0ebe8c9a4b054fc598a8802d49c845482023-11-20T00:06:00ZengMDPI AGMolecules1420-30492020-05-01259226510.3390/molecules25092265Predicting Drug Resistance Using Deep Mutational ScanningGur Pines0Reilly G. Fankhauser1Carrie A. Eckert2Department of Entomology, Agricultural Research Organization, Volcani Center, P.O.B 15159, Rishon LeZion 7505101, IsraelDepartment of Dermatology, Oregon Health & Science University, Baird Hall 3225 SW Pavilion Loop, Portland, OR 97239, USARenewable and Sustainable Energy Institute, University of Colorado Boulder, 027 UCB, Boulder, CO 80309, USADrug resistance is a major healthcare challenge, resulting in a continuous need to develop new inhibitors. The development of these inhibitors requires an understanding of the mechanisms of resistance for a critical mass of occurrences. Recent genome editing technologies based on high-throughput DNA synthesis and sequencing may help to predict mutations resulting in resistance by testing large mutagenesis libraries. Here we describe the rationale of this approach, with examples and relevance to drug development and resistance in malaria.https://www.mdpi.com/1420-3049/25/9/2265sequence to activity mappinggenome editingfosmidomycinDXRdrug resistance
spellingShingle Gur Pines
Reilly G. Fankhauser
Carrie A. Eckert
Predicting Drug Resistance Using Deep Mutational Scanning
Molecules
sequence to activity mapping
genome editing
fosmidomycin
DXR
drug resistance
title Predicting Drug Resistance Using Deep Mutational Scanning
title_full Predicting Drug Resistance Using Deep Mutational Scanning
title_fullStr Predicting Drug Resistance Using Deep Mutational Scanning
title_full_unstemmed Predicting Drug Resistance Using Deep Mutational Scanning
title_short Predicting Drug Resistance Using Deep Mutational Scanning
title_sort predicting drug resistance using deep mutational scanning
topic sequence to activity mapping
genome editing
fosmidomycin
DXR
drug resistance
url https://www.mdpi.com/1420-3049/25/9/2265
work_keys_str_mv AT gurpines predictingdrugresistanceusingdeepmutationalscanning
AT reillygfankhauser predictingdrugresistanceusingdeepmutationalscanning
AT carrieaeckert predictingdrugresistanceusingdeepmutationalscanning